COM:MEDICINOVA
MediciNova, Inc.
- Stock
Last Close
2.00
22/11 21:00
Market Cap
67.68M
Beta: -
Volume Today
63.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 262.87K - | 247.93K 5.68% | 316.38K 27.61% | 269.03K 14.97% | 943.75K 250.80% | 1.07M 13.22% | 534.04K 50.02% | 533.98K 0.01% | 509.68K 4.55% | 413.69K 18.83% | 714.29K 72.66% | |
average receivables | 3.00M - | 3.00M 0% | ||||||||||
book value per share | 1.23 - | 0.91 25.55% | 1.23 34.75% | 1.05 15.05% | 1.10 5.05% | 1.78 61.64% | 1.74 2.38% | 1.61 7.45% | 1.72 7.22% | 1.43 16.82% | 1.27K 88,703.79% | |
capex per share | -0.00 - | -0.00 92.71% | -0.00 40.37% | -0.00 2,834.11% | -0.00 - | -0.00 5.30% | -0.00 214.60% | -0.00 28.04% | -0.00 82.72% | -0.43 425,024.04% | ||
capex to depreciation | -0.41 - | -0.09 78.80% | -0.09 0.90% | -5.98 6,783.47% | -0.39 - | -0.47 19.45% | -1.71 263.21% | -1.10 35.74% | -0.28 74.25% | -1.05 270.92% | ||
capex to operating cash flow | 0.00 - | -0.00 210.54% | 0.00 107.52% | 0.01 3,878.70% | 0.00 - | 0.00 10.38% | 0.00 172.86% | 0.00 9.14% | 0.00 87.33% | 0.00 638.67% | ||
capex to revenue | -0.01 - | -0.01 - | -0.02 - | |||||||||
cash per share | 0.32 - | 0.48 49.77% | 0.83 71.31% | 0.73 11.98% | 0.80 8.96% | 1.52 90.20% | 1.48 2.45% | 1.35 8.55% | 1.47 8.74% | 1.19 18.87% | 1.04K 87,095.69% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 18.06K - | |||||||||||
days sales outstanding | 365.32 - | |||||||||||
debt to assets | -57.34 - | -61.43 7.13% | -44.36 27.79% | -42.53 4.13% | -78.04 83.49% | -21.59 72.34% | -21.39 0.91% | -22.46 5.02% | 0.00 100.01% | 0.00 40.68% | 0.00 53.40% | |
debt to equity | -66.63 - | -76.12 14.24% | -51.34 32.55% | -49.03 4.49% | -87.68 78.83% | -22.80 74.00% | -22.62 0.79% | -23.75 5.00% | 0.00 100.01% | 0.00 42.18% | 0.00 54.37% | |
dividend yield | ||||||||||||
earnings yield | -0.09 - | -0.13 38.18% | -0.09 25.41% | -0.05 41.73% | -0.05 10.11% | -0.04 11.05% | -0.04 1.86% | -0.06 33.29% | -0.08 31.21% | -0.14 79.83% | -116.51 83,162.34% | |
enterprise value | 37.59M - | 80.24M 113.46% | 84.96M 5.87% | 175.76M 106.88% | 199.34M 13.42% | 300.89M 50.94% | 227.10M 24.52% | 173.58M 23.57% | 58.94M 66.04% | 82.19M 39.46% | -50.71M 161.69% | |
enterprise value over ebitda | -9.59 - | -8.76 8.63% | -9.64 10.05% | -16.20 68.03% | -15.48 4.47% | -19.34 24.92% | -16.21 16.15% | -12.26 24.38% | -5.78 52.82% | -5.63 2.74% | 5.13 191.24% | |
ev to operating cash flow | -3.53 - | 98.28 2,883.26% | -11.88 112.09% | -26.85 126.03% | -28.79 7.23% | -33.01 14.67% | -24.89 24.61% | -16.03 35.58% | -6.28 60.82% | -6.37 1.33% | 6.82 207.20% | |
ev to sales | 6.26 - | 14.60 - | -50.71 - | |||||||||
free cash flow per share | -0.52 - | 0.03 106.54% | -0.27 896.89% | -0.20 25.33% | -0.20 1.97% | -0.22 12.59% | -0.21 4.59% | -0.24 15.54% | -0.19 20.83% | -0.26 36.00% | -151.95 57,595.16% | |
free cash flow yield | -0.24 - | 0.01 104.60% | -0.08 782.41% | -0.03 56.04% | -0.03 8.63% | -0.03 10.84% | -0.03 15.66% | -0.05 48.05% | -0.07 55.39% | -0.13 77.80% | -101.30 78,750.05% | |
graham net net | 0.34 - | 0.27 22.25% | 0.64 139.20% | 0.57 10.32% | 0.66 15.70% | 1.42 114.19% | 1.38 2.61% | 1.26 8.60% | 1.39 10.60% | 1.11 20.13% | 960.48 86,216.81% | |
graham number | 2.32 - | 2.80 20.88% | 3.04 8.34% | 2.79 8.30% | 2.80 0.66% | 3.78 34.74% | 3.42 9.43% | 3.36 1.88% | 2.84 15.34% | 3.04 6.96% | 2.24K 73,454.42% | |
income quality | 2.64 - | -0.09 103.36% | 0.81 1,010.63% | 0.60 25.50% | 0.62 2.95% | 0.62 0.13% | 0.71 13.53% | 0.78 10.83% | 0.93 18.46% | 0.92 0.86% | 0.87 5.53% | |
intangibles to total assets | 0.49 - | 0.53 8.33% | 0.38 28.05% | 0.36 4.79% | 0.33 8.30% | 0.19 43.77% | 0.18 2.50% | 0.19 5.02% | 0.16 13.71% | 0.19 17.87% | 0.22 11.90% | |
interest coverage | -14.69K - | -17.16K 16.87% | -23.97K 39.64% | -43.72K 82.38% | 26.01 - | |||||||
interest debt per share | -81.85 - | -69.61 14.96% | -63.26 9.12% | -51.33 18.86% | -96.43 87.87% | -40.53 57.97% | -39.25 3.16% | -38.15 2.82% | 0.00 100.01% | -0.01 404.00% | 4.40 53,429.75% | |
inventory turnover | ||||||||||||
invested capital | -66.63 - | -76.12 14.24% | -51.34 32.55% | -49.03 4.49% | -87.68 78.83% | -22.80 74.00% | -22.62 0.79% | -23.75 5.00% | 0.00 100.01% | 0.00 42.18% | 0.00 54.37% | |
market cap | 44.29M - | 73.17M 65.19% | 94.35M 28.96% | 198.91M 110.81% | 227.34M 14.29% | 335.99M 47.79% | 290.89M 13.42% | 233.61M 19.69% | 130.24M 44.25% | 100.54M 22.80% | 73.57K 99.93% | |
net current asset value | 10.26M - | 6.87M 33.05% | 17.57M 155.79% | 19.42M 10.53% | 23.55M 21.26% | 58.64M 149.00% | 59.99M 2.30% | 56.62M 5.62% | 68.28M 20.58% | 55.07M 19.34% | 47.28M 14.15% | |
net debt to ebitda | 1.71 - | -0.77 145.22% | 1.07 237.99% | 2.13 100.11% | 2.17 1.84% | 2.26 3.79% | 4.55 101.89% | 4.24 6.88% | 7.00 65.00% | 1.26 82.05% | 5.14 309.31% | |
net income per share | -0.19 - | -0.38 96.29% | -0.33 12.90% | -0.33 1.02% | -0.32 3.55% | -0.36 12.32% | -0.30 15.97% | -0.31 4.02% | -0.21 33.15% | -0.29 37.56% | -174.76 60,823.67% | |
operating cash flow per share | -0.51 - | 0.03 106.60% | -0.27 893.19% | -0.20 26.25% | -0.20 0.70% | -0.22 12.47% | -0.21 4.60% | -0.24 15.29% | -0.19 20.80% | -0.26 36.37% | -151.51 57,452.59% | |
payables turnover | 0.02 - | |||||||||||
receivables turnover | 1.00 - | |||||||||||
research and ddevelopement to revenue | 0.56 - | 2.11 - | 5.66 - | |||||||||
return on tangible assets | -0.27 - | -0.71 168.55% | -0.38 47.32% | -0.43 13.63% | -0.38 10.03% | -0.23 39.28% | -0.20 14.51% | -0.23 13.69% | -0.14 38.86% | -0.24 69.61% | -0.17 29.81% | |
revenue per share | 0.29 - | 0.08 - | 20.39 - | |||||||||
roe | -0.16 - | -0.42 163.67% | -0.27 35.36% | -0.31 16.52% | -0.29 8.19% | -0.20 30.51% | -0.17 13.92% | -0.19 12.40% | -0.12 37.65% | -0.20 65.38% | -0.14 31.40% | |
roic | 0.00 - | 0.01 133.84% | 0.01 4.30% | 0.01 21.67% | 0.00 48.78% | 0.01 195.90% | 0.01 12.85% | 0.01 0.72% | -0.12 1,493.51% | -0.21 70.35% | -0.16 23.96% | |
sales general and administrative to revenue | 1.11 - | 1.42 - | 5.24 - | |||||||||
shareholders equity per share | 1.23 - | 0.91 25.55% | 1.23 34.75% | 1.05 15.05% | 1.10 5.05% | 1.78 61.64% | 1.74 2.38% | 1.61 7.45% | 1.72 7.22% | 1.43 16.82% | 1.27K 88,703.79% | |
stock based compensation to revenue | 0.20 - | 0.43 - | 0.71 - | |||||||||
tangible asset value | 11.03M - | 7.61M 30.98% | 18.35M 141.15% | 20.13M 9.69% | 24.24M 20.42% | 58.71M 142.17% | 60.49M 3.04% | 56.93M 5.90% | 69.28M 21.70% | 55.84M 19.39% | 47.98M 14.08% | |
tangible book value per share | 0.53 - | 0.32 40.64% | 0.69 118.37% | 0.61 11.62% | 0.69 13.05% | 1.43 106.91% | 1.40 1.81% | 1.28 8.56% | 1.43 11.22% | 1.14 20.13% | 978.23 85,816.90% | |
working capital | 13.92M - | 10.54M 24.30% | 21.24M 101.50% | 23.07M 8.66% | 25.45M 10.29% | 60.57M 138.01% | 62.08M 2.49% | 58.52M 5.72% | 69.18M 18.20% | 55.80M 19.34% | 47.90M 14.17% |
All numbers in (except ratios and percentages)